These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21487418)

  • 1. Prevention: long-term benefits of tamoxifen.
    Hutchinson L
    Nat Rev Clin Oncol; 2011 Jun; 8(6):317. PubMed ID: 21487418
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of antiestrogens for prevention of breast cancer.
    Reddy P; Chow MS
    Am J Health Syst Pharm; 2000 Jul; 57(14):1315-22; quiz 1323-5. PubMed ID: 10918921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.
    Jordan VC
    Br J Pharmacol; 1993 Oct; 110(2):507-17. PubMed ID: 8242225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
    Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
    Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen and related compounds protect against lipid peroxidation in isolated nuclei: relevance to the potential anticarcinogenic benefits of breast cancer prevention and therapy with tamoxifen?
    Wiseman H; Halliwell B
    Free Radic Biol Med; 1994 Nov; 17(5):485-8. PubMed ID: 7835756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.
    Jordan VC; Obiorah I; Fan P; Kim HR; Ariazi E; Cunliffe H; Brauch H
    Breast; 2011 Oct; 20 Suppl 3(Suppl 3):S1-11. PubMed ID: 22015273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tamoxifen in the prevention and treatment of benign and malignant breast lesions: a chemopreventive.
    Leis HP
    Int Surg; 1993; 78(2):176-82. PubMed ID: 8354620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits and costs of tamoxifen for breast cancer prevention.
    Eckermann SD; Martin AJ; Stockler MR; Simes RJ
    Aust N Z J Public Health; 2003; 27(1):34-40. PubMed ID: 14705265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
    Gail MH; Costantino JP; Bryant J; Croyle R; Freedman L; Helzlsouer K; Vogel V
    J Natl Cancer Inst; 1999 Nov; 91(21):1829-46. PubMed ID: 10547390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tamoxifen in the long-term treatment and prevention of breast cancer.
    Jordan VC
    Oncology (Williston Park); 1988 Sep; 2(9):19-28. PubMed ID: 3079292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM; Christo DK; Lai H; Helzlsouer K
    Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.
    Kunath F; Keck B; Antes G; Wullich B; Meerpohl JJ
    BMC Med; 2012 Aug; 10():96. PubMed ID: 22925442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.
    Veronesi U; Maisonneuve P; Costa A; Sacchini V; Maltoni C; Robertson C; Rotmensz N; Boyle P
    Lancet; 1998 Jul; 352(9122):93-7. PubMed ID: 9672273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk-benefit assessment of tamoxifen therapy.
    Catherino WH; Jordan VC
    Drug Saf; 1993 May; 8(5):381-97. PubMed ID: 8504018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of the prevention and treatment of breast cancer--present status and open issues.
    Imai H; Kuroi K; Ohsumi S; Ono M; Shimozuma K
    Breast Cancer; 2007; 14(1):81-7. PubMed ID: 17245000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of breast cancer.
    Osborne MP
    Surg Clin North Am; 1999 Oct; 79(5):1207-21. PubMed ID: 10572559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer.
    Schwartz LM; Woloshin S
    JAMA; 2002 Jun; 287(23):3136-42. PubMed ID: 12069679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen for prevention of breast cancer.
    Cersosimo RJ
    Ann Pharmacother; 2003 Feb; 37(2):268-73. PubMed ID: 12549959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group.
    Delozier T; Spielmann M; Macé-Lesec'h J; Janvier M; Hill C; Asselain B; Julien JP; Weber B; Mauriac L; Petit JC; Kerbrat P; Malhaire JP; Vennin P; Leduc B; Namer M
    J Clin Oncol; 2000 Oct; 18(20):3507-12. PubMed ID: 11032592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.